AMO 5G femtosecond laser cleared by FDA

Article

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The fifth generation laser, which can cut a corneal flap within 10 seconds, includes IntraLase-Enabled Keratoplasty (IEK), and has a higher repetition rate and tighter spot separation than earlier models. It has a unique inverted bevel-in-side cut angle to improve the biomechanical stability of postoperative corneas, and can create an elliptical flap to increase the number of surgical options.

The iFS laser - part of AMO's proprietary iLASIK technology suite - has an ergonomic design, new contemporary user interface and high-resolution digital video microscope, all designed to increase surgeon comfort and ease of operating, enhancing the outcome for the patient.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.